Clinical studies have followed people taking Wegovy ( semaglutide ) for up to 68 weeks , Zepbound ( tirzepatide ) for up to 88 weeks , and Foundayo ( orforglipron ) for up to 72 weeks , showing that weight loss can continue with ongoing treatment
Invest Clin 2007;48(2):243-248
Visiting our IV Lounge in Toronto At the TFMC, our functional medicine and IV therapy providers tailor treatments for various health conditions, especially those linked to immune and cognitive function, sports performance, chronic fatigue syndrome, muscle recovery, cellular damage, hormonal imbalances, nutrient deficiencies, stress management, chronic inflammation, support for blood pressure regulation, liver detoxification, and other health concerns
These conditions are associated with thyroid C-cell tumors, and animal studies have linked tirzepatide to such tumors